LIFE-BTK 3-Year Data Sustain Positive Outlook for CLTI Patients Treated With Drug-Eluting Scaffold

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650.00 annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

LIFE-BTK 3-Year Data Sustain Positive Outlook for CLTI Patients Treated With Drug-Eluting Scaffold

Posted: 05/14/2026
Author:
Bailey G. Salimes, CRTonline.org
Peripheral Vascular Interventions 2026 News Articles News Popliteal Endovascular Critical Limb Ischemia Below-the-Knee Limb Ischemia

Patients with chronic limb-threatening ischemia (CLTI) from infrapopliteal disease have better long-term clinical outcomes when they receive the Esprit BTK drug-eluting resorbable scaffold (DRS) versus percutaneous transluminal angioplasty (PTA), 3-year results from the LIFE-BTK trial show.

Invalid Configuration Data. Please look into Pipeline and other configurations.

No record found for the searched term.

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

LIFE-BTK 3-Year Data Sustain Positive Outlook for CLTI Patients Treated With Drug-Eluting Scaffold

Most Viewed Pages

Explore the Site

Stay Connected